New ultrasound trick could spare women unnecessary breast biopsies

NCT ID NCT07465523

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new way to use Doppler ultrasound to better tell the difference between benign (non-cancerous) and malignant (cancerous) breast lumps. Researchers will measure blood flow resistance in the lump and compare it to healthy breast tissue. If the method works, it could help doctors decide which lumps need a biopsy and which do not. The study involves 90 women with solid breast masses who already have pathology results.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could provide a non-invasive way to more accurately distinguish between benign and malignant breast lumps, potentially reducing the need for biopsies.
What could go wrong
This is a small, early-stage study with only 90 participants. The method may not prove reliable enough for widespread use, and results may not apply to all breast mass types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN BREAST NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Karamanoğlu Mehmetbey University, KEAH

    RECRUITING

    Karaman, Lütfen Seçiniz., 70200, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.